查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088724

蛋白質工程市場：按類型、技術平台、蛋白質類型、宿主生物、應用和最終用戶分類－2026-2032年全球市場預測

Protein Engineering Market by Type, Technology Platform, Protein Type, Host Organism, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，蛋白質工程市場將成長至 95.1 億美元，複合年成長率為 11.08%。

主要市場統計數據
基準年 2025 45.5億美元
預計年份：2026年 49.8億美元
預測年份 2032 95.1億美元
複合年成長率 (%) 11.08%

蛋白質工程執行摘要

蛋白質工程正從一個專門的研究領域轉變為生物製藥、工業生物技術、診斷、農業、食品技術和永續材料的核心平台。該領域結合了理性設計、定向進化、合成生物學和計算建模，旨在創造具有更高親和性、穩定性、特異性、表達產量和可生產性的蛋白質。

蛋白質工程領域的變革性變化

高通量DNA合成、次世代定序、自動化液體處理、微流體技術和無細胞表現系統正在重新定義蛋白質工程領域。這些工具使研究團隊能夠測試大規模的變體庫，縮短設計-構建-測試-學習週期，並提高可重複性。

人工智慧的累積影響

人工智慧如今已成為結構預測、序列最佳化、從頭蛋白質設計和可行性評估等領域的重要驅動力。 DeepMind 和 EMBL-EBI 共同開發的 AlphaFold 蛋白質結構資料庫提供了超過 2 億個預測的蛋白質結構，增強了全球對結構生物學資源的訪問，並支持快速生成假設。

各區域主要趨勢

北美憑藉著美國和加拿大強大的生物製藥生態系統、大學衍生公司、創業投資資金、FDA良好記錄、NIH支持的生物醫學研究以及先進的合約開發和生產能力，仍然是蛋白質工程領域的領先地區。歐洲則憑藉其在符合EMA標準的全面法規、公共研究經費、成熟的製藥產業叢集以及覆蓋德國、英國、法國、義大利和西班牙的轉化科學網路方面的優勢，繼續保持領先地位。

關鍵的群體特定見解

隨著新加坡、馬來西亞、泰國、印尼、越南和菲律賓不斷擴大其生物醫學研究、臨床基礎設施、生物技術激勵措施和生產能力，東協市場的重要性日益凸顯。海灣合作理事會成員國正利用其國家衛生戰略和經濟多元化戰略，吸引生物製藥生產、精準醫療投資、基因組學計畫以及區域生命科學夥伴關係。

主要國家的概況

美國在國立衛生研究院 (NIH) 資助的科學研究、成熟的食品藥物管理局管理局 (FDA)管理體制、生物技術創業投資主導、臨床試驗密度以及強大的生物製造能力方面均處於領先地位。加拿大則擁有強大的學術叢集、生物製劑專業知識和轉化研究計畫。墨西哥支持區域製造一體化和近岸供應鏈發展機遇，而巴西則擁有公共疫苗機構、對生物製藥的需求、臨床研究能力以及在公共衛生領域多年的製造經驗。

為行業領導者提供的實用建議

產業領導者應將人工智慧驅動的蛋白質設計與自動化實驗、穩健的檢測設計、早期開發可行性篩檢和可生產性評估相結合。投資應優先考慮檢驗的資料集、蛋白質表現平台、分析表徵、製劑科學和可擴展的純化工藝，而不是孤立的演算法工具。

調查方法

本執行摘要基於公開可取得和可驗證的來源，包括監管文件、同行評審的科學文獻、專利趨勢、臨床檢驗註冊資訊、公共資金公告以及來自 FDA、EMA、NIH、WHO、OECD、WIPO、ClinicalTrials.gov 和 EMBL-EBI 的資訊來源。

結論

蛋白質工程正成為下一代療法、永續生物製造、先進診斷、食品系統創新和韌性醫療保健系統的策略基礎。人工智慧、自動化、合成生物學、結構生物學和檢驗的濕實驗室工作流程的結合，正在拓展機構的設計、測試、最佳化和製造能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：蛋白質工程市場：依類型分類

  • 酵素工程
    • 工業酵素
    • 醫用酶
    • 診斷酶
  • 抗體工程
    • 單株抗體
    • 多克隆抗體
  • 蛋白質設計
    • 從頭蛋白質設計
    • 合理蛋白質設計
  • 蛋白質最佳化
  • 蛋白質修飾
    • 糖工程
    • 聚乙二醇化

第8章：蛋白質工程市場：依技術平台分類

  • 定向演化
    • DNA重組
    • 易出錯的PCR
  • 基因合成
    • 基因片段合成
    • 合成基因組裝
  • 位點特異性突變誘導
    • 隨機突變引入
    • 理性突變引入

第9章：蛋白質工程市場：依蛋白質類型分類

  • 胰島素
  • 單株抗體
  • 疫苗
  • 酵素
  • 荷爾蒙
  • 細胞激素

第10章：蛋白質工程市場：依宿主生物體分類

  • 原核系統
  • 真核系統
  • 合成宿主

第11章：蛋白質工程市場：依應用領域分類

  • 農業生物技術
    • 作物改良
    • 抗蟲害
  • 工業酵素工程
    • 生質燃料
    • 清潔劑
  • 治療性蛋白質的開發
    • 單株抗體
    • 疫苗

第12章：蛋白質工程市場：依最終用戶分類

  • 學術研究機構
  • 生技公司
  • 受託研究機構
  • 製藥公司

第13章：蛋白質工程市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：蛋白質工程市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 蛋白質工程市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Absci Corp
  • Abzena Ltd
  • Adimab LLC
  • Agilent Technologies Inc
  • Amgen Inc
  • Arzeda Corp
  • BigHat Biosciences Inc
  • Bio-Rad Laboratories Inc
  • Bruker Corporation
  • Charles River Laboratories International Inc
  • Codexis Inc
  • Danaher Corporation
  • Evotec SE
  • Genentech Inc
  • Generate Biomedicines Inc
  • GenScript Biotech Corporation
  • Ginkgo Bioworks Inc
  • Lonza Group Ltd
  • Merck KGaA
  • Novo Nordisk A/S
  • Nuclera Nucleics Ltd
  • Profluent Bio Inc
  • ProteinQure Inc
  • Sino Biological Inc
  • Sutro Biopharma Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp
  • Waters Corp
  • WuXi AppTec Co Ltd
  • Zymeworks Inc
Product Code: MRR-B9334AD6BE67

The Protein Engineering Market is projected to grow by USD 9.51 billion at a CAGR of 11.08% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.55 billion
Estimated Year [2026] USD 4.98 billion
Forecast Year [2032] USD 9.51 billion
CAGR (%) 11.08%

Protein Engineering Executive Summary

Protein engineering is moving from a specialized research capability to a core platform for biopharmaceuticals, industrial biotechnology, diagnostics, agriculture, food technology, and sustainable materials. The field combines rational design, directed evolution, synthetic biology, and computational modeling to create proteins with improved affinity, stability, specificity, expression yield, and manufacturability.

Demand is supported by established evidence across approved recombinant therapeutics, monoclonal antibodies, enzymes, vaccines, and diagnostic reagents. As organizations seek faster discovery cycles and more resilient biomanufacturing, protein engineering is increasingly tied to artificial intelligence, automation, high-throughput screening, structural biology, and quality-by-design strategies.

Transformative Shifts in the Protein Engineering Landscape

The protein engineering landscape is being reshaped by high-throughput DNA synthesis, next-generation sequencing, automated liquid handling, microfluidics, and cell-free expression systems. These tools allow teams to test larger variant libraries and shorten the design-build-test-learn cycle while improving reproducibility.

Commercial priorities are also shifting. Biopharma teams are engineering antibodies, enzymes, cytokines, fusion proteins, and gene-editing components for better safety, potency, half-life, and durability, while industrial users are adopting engineered enzymes to lower energy use, reduce solvent dependence, improve process selectivity, and support circular manufacturing models.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is now a major accelerator for structure prediction, sequence optimization, de novo protein design, and developability assessment. DeepMind and EMBL-EBI's AlphaFold Protein Structure Database has made more than 200 million predicted protein structures available, strengthening global access to structural biology resources and supporting faster hypothesis generation.

The impact is cumulative rather than standalone: AI improves protein modeling and variant prioritization, but wet-lab validation, biophysical characterization, immunogenicity evaluation, toxicity assessment, and regulatory documentation remain essential. Leaders are integrating machine learning with validated datasets, laboratory automation, and governance controls to reduce failed experiments and improve translation from in silico design to manufacturable products.

Key Regional Insights

North America remains a leading region for protein engineering due to strong U.S. and Canadian biopharma ecosystems, university spinouts, venture funding, FDA experience, NIH-supported biomedical research, and advanced contract development and manufacturing capacity. Europe benefits from EMA-aligned regulatory depth, public research funding, established pharmaceutical clusters, and translational science networks across Germany, the United Kingdom, France, Italy, and Spain.

Asia-Pacific is expanding through China's biotech scale-up, India's biologics and vaccine manufacturing base, Japan's precision science infrastructure, South Korea's biologics CDMO strength, and Australia's translational research networks. Latin America is led by Brazil and Mexico in public health manufacturing, clinical demand, and regional supply-chain integration. The Middle East, especially Gulf economies, is investing in healthcare localization, genomics, and precision medicine infrastructure, while Africa is building vaccine and biologics capacity through public-private initiatives supported by international health agencies and regional manufacturing programs.

Key Group Insights

ASEAN markets are gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand biomedical research, clinical infrastructure, biotechnology incentives, and manufacturing capabilities. The GCC is using national healthcare and economic diversification strategies to attract biologics production, precision medicine investment, genomic programs, and regional life science partnerships.

The European Union provides a large regulated environment supported by Horizon Europe funding, EMA guidance, cross-border research networks, and harmonized quality standards. BRICS countries contribute scale in manufacturing, patient populations, clinical research, and public-sector biotechnology. G7 economies remain central to advanced discovery, intellectual property creation, regulatory science, and high-value biomanufacturing, while NATO countries increasingly view biosecurity, supply-chain resilience, pathogen preparedness, and dual-use risk management as strategic priorities for protein engineering and synthetic biology.

Key Country Insights

The United States leads through NIH-funded science, FDA regulatory maturity, venture-backed biotechnology, clinical trial density, and deep biomanufacturing capacity, while Canada offers strong academic clusters, biologics expertise, and translational research programs. Mexico supports regional manufacturing integration and nearshore supply-chain opportunities, and Brazil contributes public vaccine institutions, biopharma demand, clinical research capacity, and long-standing public health manufacturing experience.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine pharmaceutical manufacturing, academic excellence, clinical networks, regulatory experience, and skilled bioprocessing talent, while Russia maintains domestic biotechnology capabilities and scientific infrastructure. China is scaling discovery and manufacturing under NMPA oversight; India is a major vaccine, biosimilar, and biologics producer; Japan emphasizes quality, precision regulation, and advanced life sciences; Australia supports translational medicine and clinical development; and South Korea is a global biologics CDMO and biosimilars hub supported by government-backed biomanufacturing ambitions.

Actionable Recommendations for Industry Leaders

Industry leaders should connect AI-enabled protein design with automated experimentation, robust assay design, early developability screening, and manufacturability assessment. Investment should prioritize validated datasets, protein expression platforms, analytical characterization, formulation science, and scalable purification processes rather than isolated algorithmic tools.

Organizations should also strengthen regulatory readiness, intellectual property strategy, supplier redundancy, cybersecurity, and biosecurity oversight. Partnerships with academic laboratories, CDMOs, cloud laboratories, standards bodies, and regional innovation agencies can accelerate access to talent, infrastructure, specialized assays, and market-specific compliance knowledge.

Research Methodology

This executive summary is grounded in publicly available and verifiable sources, including regulatory agency materials, peer-reviewed scientific literature, patent landscapes, clinical trial registries, public funding announcements, and recognized institutional databases such as FDA, EMA, NIH, WHO, OECD, WIPO, ClinicalTrials.gov, and EMBL-EBI resources.

Insights were triangulated across scientific, commercial, regulatory, and regional indicators. Claims were framed conservatively to avoid unsupported market sizing, market share, or forecasting, and qualitative conclusions were derived from observable technology adoption, approved biologics activity, manufacturing investment, public research programs, and documented advances in computational protein science.

Conclusion

Protein engineering is becoming a strategic foundation for next-generation therapeutics, sustainable biomanufacturing, advanced diagnostics, food system innovation, and resilient health systems. The combination of AI, automation, synthetic biology, structural biology, and validated wet-lab workflows is expanding what organizations can design, test, optimize, and manufacture.

Success will depend on disciplined execution: high-quality data, experimentally confirmed performance, scalable production, regulatory alignment, biosecurity governance, and responsible innovation. Organizations that integrate these capabilities early will be better positioned to capture value across biopharma, industrial enzymes, food systems, precision medicine, and sustainable biotechnology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Protein Engineering Market, by Type

  • 7.1. Enzyme Engineering
    • 7.1.1. Industrial Enzymes
    • 7.1.2. Medical Enzymes
    • 7.1.3. Diagnostic Enzymes
  • 7.2. Antibody Engineering
    • 7.2.1. Monoclonal
    • 7.2.2. Polyclonal
  • 7.3. Protein Design
    • 7.3.1. De novo Protein Design
    • 7.3.2. Rational Protein Design
  • 7.4. Protein Optimization
  • 7.5. Protein Modification
    • 7.5.1. Glycoengineering
    • 7.5.2. PEGylation

8. Protein Engineering Market, by Technology Platform

  • 8.1. Directed Evolution
    • 8.1.1. DNA Shuffling
    • 8.1.2. Error Prone Pcr
  • 8.2. Gene Synthesis
    • 8.2.1. Gene Fragment Synthesis
    • 8.2.2. Synthetic Gene Assembly
  • 8.3. Site Directed Mutagenesis
    • 8.3.1. Random Mutagenesis
    • 8.3.2. Rational Mutagenesis

9. Protein Engineering Market, by Protein Type

  • 9.1. Insulin
  • 9.2. Monoclonal Antibodies
  • 9.3. Vaccines
  • 9.4. Enzymes
  • 9.5. Hormones
  • 9.6. Cytokines

10. Protein Engineering Market, by Host Organism

  • 10.1. Prokaryotic Systems
  • 10.2. Eukaryotic Systems
  • 10.3. Synthetic Hosts

11. Protein Engineering Market, by Application

  • 11.1. Agricultural Biotechnology
    • 11.1.1. Crop Improvement
    • 11.1.2. Pest Resistance
  • 11.2. Industrial Enzyme Engineering
    • 11.2.1. Biofuels
    • 11.2.2. Detergents
  • 11.3. Therapeutic Protein Development
    • 11.3.1. Monoclonal Antibodies
    • 11.3.2. Vaccines

12. Protein Engineering Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical Companies

13. Protein Engineering Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Protein Engineering Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Protein Engineering Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Absci Corp
  • 17.2. Abzena Ltd
  • 17.3. Adimab LLC
  • 17.4. Agilent Technologies Inc
  • 17.5. Amgen Inc
  • 17.6. Arzeda Corp
  • 17.7. BigHat Biosciences Inc
  • 17.8. Bio-Rad Laboratories Inc
  • 17.9. Bruker Corporation
  • 17.10. Charles River Laboratories International Inc
  • 17.11. Codexis Inc
  • 17.12. Danaher Corporation
  • 17.13. Evotec SE
  • 17.14. Genentech Inc
  • 17.15. Generate Biomedicines Inc
  • 17.16. GenScript Biotech Corporation
  • 17.17. Ginkgo Bioworks Inc
  • 17.18. Lonza Group Ltd
  • 17.19. Merck KGaA
  • 17.20. Novo Nordisk A/S
  • 17.21. Nuclera Nucleics Ltd
  • 17.22. Profluent Bio Inc
  • 17.23. ProteinQure Inc
  • 17.24. Sino Biological Inc
  • 17.25. Sutro Biopharma Inc
  • 17.26. Thermo Fisher Scientific Inc
  • 17.27. Twist Bioscience Corp
  • 17.28. Waters Corp
  • 17.29. WuXi AppTec Co Ltd
  • 17.30. Zymeworks Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN ENGINEERING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PROTEIN ENGINEERING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PROTEIN ENGINEERING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PROTEIN ENGINEERING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEIN ENGINEERING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PROTEIN ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INDUSTRIAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INDUSTRIAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INDUSTRIAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIBODY ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTIBODY ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIBODY ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MONOCLONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MONOCLONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MONOCLONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYCLONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYCLONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYCLONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PROTEIN DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROTEIN DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROTEIN DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DE NOVO PROTEIN DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DE NOVO PROTEIN DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DE NOVO PROTEIN DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RATIONAL PROTEIN DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RATIONAL PROTEIN DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RATIONAL PROTEIN DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PROTEIN OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PROTEIN OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROTEIN OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROTEIN MODIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROTEIN MODIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROTEIN MODIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLYCOENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GLYCOENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLYCOENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PEGYLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PEGYLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PEGYLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DNA SHUFFLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DNA SHUFFLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DNA SHUFFLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ERROR PRONE PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ERROR PRONE PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ERROR PRONE PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GENE FRAGMENT SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GENE FRAGMENT SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GENE FRAGMENT SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SYNTHETIC GENE ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SYNTHETIC GENE ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SYNTHETIC GENE ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SITE DIRECTED MUTAGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SITE DIRECTED MUTAGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SITE DIRECTED MUTAGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RANDOM MUTAGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RANDOM MUTAGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RANDOM MUTAGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RATIONAL MUTAGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RATIONAL MUTAGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RATIONAL MUTAGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INSULIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INSULIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INSULIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CYTOKINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CYTOKINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CYTOKINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROKARYOTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PROKARYOTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PROKARYOTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL EUKARYOTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL EUKARYOTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL EUKARYOTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SYNTHETIC HOSTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SYNTHETIC HOSTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SYNTHETIC HOSTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CROP IMPROVEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CROP IMPROVEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CROP IMPROVEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PEST RESISTANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PEST RESISTANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PEST RESISTANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL INDUSTRIAL ENZYME ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INDUSTRIAL ENZYME ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INDUSTRIAL ENZYME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOFUELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOFUELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOFUELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DETERGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DETERGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DETERGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL THERAPEUTIC PROTEIN DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL THERAPEUTIC PROTEIN DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL THERAPEUTIC PROTEIN DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. GCC PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. GCC PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 267. GCC PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 268. GCC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 269. GCC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 280. GCC PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. G7 PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. G7 PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. G7 PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 318. G7 PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 319. G7 PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 320. G7 PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 321. G7 PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 322. G7 PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 323. G7 PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 324. G7 PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 325. G7 PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. G7 PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 327. G7 PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 328. G7 PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. G7 PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 330. G7 PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 331. G7 PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. NATO PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 335. NATO PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 336. NATO PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 337. NATO PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
  • TABLE 338. NATO PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 339. NATO PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
  • TABLE 340. NATO PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
  • TABLE 341. NATO PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
  • TABLE 342. NATO PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. NATO PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
  • TABLE 344. NATO PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 345. NATO PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 346. NATO PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 347. NATO PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 348. NATO PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 349. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION,